Osteoarthritis Trial, Recruiting NCT07706569 Sponsor: Antalya Training and Research Hospital Condition: Osteoarthritis
Back to Osteoarthritis

Osteoarthritis Trial, Recruiting

NCT07706569
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been diagnosed with knee osteoarthritis based on American College of Rheumatology (ACR) standards
  • People whose knee osteoarthritis has been graded as moderate to severe (Grade 2, 3, or 4) using a standard X-ray scoring system called the Kellgren-Lawrence scale
  • People who are willing to take part and have signed a consent form agreeing to participate

Who may not be able to join:

  • People whose knee osteoarthritis developed as a result of a major knee injury or a past joint infection
  • People who currently have signs of active joint inflammation, such as swelling, warmth, or redness in the knee
  • People who have had surgery on the knee in the past, whether open surgery or keyhole (arthroscopic) surgery
  • People who have a condition where the immune system attacks the body (such as rheumatoid arthritis or similar diseases)
  • People who have a history of cancer
  • People who have serious kidney or liver disease
  • People who have been diagnosed with diabetes
  • People who are currently taking steroid medications that affect the whole body (such as prednisone or cortisone tablets)
  • People who have painful osteoarthritis in other major joints, such as the hip, hand, ankle, or spine
  • People who have an active infection anywhere in the body, which may include fever, cough, diarrhoea, painful urination, or abnormal blood test results showing signs of infection

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 23 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +905079130762

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Antalya Training and Research Hospital
Registry
ClinicalTrials.gov
Start date
1 April 2026
Est. completion
30 August 2026

Where this trial is recruiting

Turkey (Türkiye)

Primary endpoints

Serum Fetuin-A Levels

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov